SBWire

IRIS International, Inc. (Iris) designs, develops, manufactures and markets in-vitro diagnostic systems that analyze particles and living cell forms and structures of a variety of body fluids. The company carries out its business through three divisions, namely, Iris Diagnostics, Iris Sample Processing and Iris Personalized Medicine. Its major products include in-vitro diagnostic urinalysis systems, integrated urinalysis software, sample collection systems, sample processing systems, benchtop centrifuges, small instruments and supplies. It also develops and commercialize NADiA ultra-sensitive nucleic acid detection immunoassay platform, with applications in oncology and infectious diseases. The company exports its products to more than 50 countries. Iris is a subsidiary of Danaher Corporation and is headquartered in California, the US.

Insight Genetics, Inc. (Insight Genetics) is a molecular diagnostics company. It focuses on the discovery, development and commercialization of companion diagnostics. The company specializes in the diagnosis, monitoring and treatment of cancer. Insight Genetics, through its lab provides cancer testing services mainly to oncologists and pharmaceutical companies. The pipeline portfolio of the company includes ROS1, RET and DEPDC1 for lung cancer and ALK ECD for breast cancer. The company offers services such as companion diagnostics services, biomarker discovery, assay design & development, clinical trial support and insight molecular labs. Some of the key partners of the company include Boston Baskin Cancer Foundation, Clarinet, Kindstar Globalgene Technology, MD Anderson Cancer Center and University of Colorado Hospital among others. Insight Genetics is headquartered in Nashville, Tennessee, the US.

Capitalizing on the in-depth expertise of its founders, Vonco Medical a leading provider of new and refurbished physical therapy and refurbished rehabilitation equipment has relocated their corporate offices to Carrollton, TX. The new facility boasts an extensive warehouse, state of the art showroom floor, conference and training rooms, service department, refurbishment department, biomed room and much more. The new facility will enable Vonco Medical to better service the more than 7500 rehabilitation facilities that they do business with.

GlobalData's new report, "Japan Cardiovascular Prosthetic Devices Market Outlook to 2020", provides key market data on the Japan Cardiovascular Prosthetic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Valve Repairs and Septal Occluders.

Amarantus BioScience has acquired rights to two diagnostic platforms for the diagnosis of neurodegenerative diseases and oncology such as nuropro diagnostic blood test platform and lympro Alzheimer's disease diagnostic blood test. The company offers treatment services for neurodegenerative diseases such as Parkinson's disease, ALS and alzheimer's disease, and cardiovascular diseases including myocardial infarction, coronary artery disease and heart failure. The company holds license to Eltoprazine, owns intellectual property rights for Mesencephalic-Astrocyte-derived Neurotrophic Factor and license to the LymPro Test. Its partners include Banyan Biomarkers, Brewer Sports International, Memory Dx, LLC, and Psychogenics, Inc. Amarantus BioSciences is headquartered in Sunnyvale, the US.

GlobalData's new report, "BRIC Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the BRIC Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

Teijin Limited (Teijin) is a technology driven holding company offering solutions in the areas of healthcare, information and electronics, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers products and services through five segments, namely, Advanced Fibers & Composites, Electric Materials & Performance Polymer Products, Healthcare and Trading and Retail. Teijin operates through its major subsidiaries in Japan, Thailand, the US, Mexico, Indonesia, the Netherlands, Germany, and China. The company sells its products in Asia, America, and Europe. Teijin is headquartered in Tokyo, Japan.

Stairlifts are invaluable convenience items for many people with difficulty or an inability to walk up stairs, but they don’t last forever. When stairlifts get past their usable life, many people may worry that a new lift is out of their price range. That’s why Mobility123 provides their customers the opportunity to rent stairlifts in Philadelphia and New Jersey. Renting costs much less than buying a new model. Mobility123’s stair lift rental program can fit any budget and patient situation.

SynCardia Systems, Inc. (SynCardia) designs, develops, manufactures, sells and implements cardiovascular devices. Its flagship product is the SynCardia temporary Total Artificial Heart, which was formally known as CardioWest Total Artificial Heart. The size and shape of the artificial heart is designed to fit in the space of the removed diseased ventricles. This product is used for the patients with end-stage biventricular failure and also serves as a bridge to human heart transplant. SynCardia's major customers include medical institutions and hospitals. SynCardia temporary Total Artificial Heart is FDA, Health Canada and CE approved and is instantly available at SynCardia Certified Centers. It sells its products in the US and the UK through its own distribution network. SynCardia is headquartered in Arizona, the US.

GlobalData's new report, "France Interventional Cardiology Market Outlook to 2020", provides key market data on the France Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).

Cook Medical Incorporated (Cook Medical), a part of Cook Group Incorporated, designs, develops and markets medical devices, biologic materials and cellular therapies for healthcare market. The company offers products in the fields of endovascular therapy, critical care medicine, gastroenterology and endoscopy procedures, general surgery, diagnostic and interventional procedures, bioengineered tissue replacement and regeneration, urology, and obstetrics and gynecology. Its major products include catheters, needles, wire guides, stents and stent grafts and other minimally invasive devices in more than 40 medical specialties. The company markets its products directly to physicians and hospitals, and also through distributors in the Americas, Europe, Asia Pacific and Africa. Cook Medical is headquartered in Bloomington, Indiana, the US.

According to the medical survey showed by Appleton health report, chlamydia cases have more than doubled in Appleton during the past decade. The city health report card shows 277 chlamydia cases in 2013, up to 129 in 2003. Chlamydia infection has been the most common sexually transmitted disease in United States. And because chlamydia has no obvious symptoms, it has been widely spread. Even worse, some diseases like prostatitis, cystitis, male and female infertility can also be induced if the chlamydia is left untreated. Thus, it is necessary to find an effective chlamydia infection treatment. According to the clinical statistics, the TCM treatment, especially the two new herbal medicine Diuretic and Anti-inflammatory Pill (for men) and Fuyan pill (for women) works on chlamydia naturally and effectively. Especially, the two new herbal medicines have good effect to the patients who have the chlamydia for long time and hardly cured by antibiotics.

June is celebrated as the national home safety month and My IDentity Doctor registers participation in all the activities related to the same, through their engraved medical bracelets that ensure safety of family members during medical emergencies. Inside home, accidents can be a result of loose railing, cords, slippery floors or bad lighting. In these circumstances, medical ID bracelets can prevent situations from turning worse if the victim is also a patient of any kind of chronic health conditions.

Caprion Inc. (Caprion) is a provider of proteomics biomarker and target identification services. It offers services such as biomarker services, in-vitro diagnostics and drug targets. Caprion provides services for target discovery and clinical validation of biomarkers using its proteomics discovery platform CellCarta. Caprion's CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious diseases, oncology and diabetes. It also provides bio analytical services, cell fractionation and sample procurement services. It has manufacturing facilities in Montreal, Quebec and Menlo Park, California, The company serves various pharmaceutical industries and clients from North America, Europe, and Asia. Caprion is headquartered in Montreal, Quebec, Canada.

GlobalData's new report, "Brazil Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Brazil Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

Genentech, Inc. (Genentech) is one of the world's leading biotech companies. The company undertakes research, development, manufacture, and marketing of biotherapeutics. Genentech focuses on developing drugs for unmet medical needs in the areas of cancer, immunological diseases and angiogenic disorders. Some of its major products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme and Activase. Its research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience. Its clinical development pipeline includes small molecules, monoclonal antibodies, and antibody drug conjugates. The company operates as a wholly owned subsidiary of Roche following its acquisition in 2009. The company is headquartered in South San Francisco, California, the US.

GlobalData's new report, "Mexico Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Mexico Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion diagnostic market for four major cancers in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this companion diagnostics market. This report analyses companion diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future of companion diagnostic tests. This report focuses on the major test kits that are supplied to pathology laboratories.

Agfa HealthCare NV (Agfa HealthCare) is a healthcare information technology company. The company develops, produces and distributes an analog and digital imaging systems and information technology solutions. Its business divisions include imaging, imaging IT solutions and healthcare information solutions. Agfa HealthCare's offers products and services in the areas of cardiology, computed radiography, image processing, dermatology, direct radiography, document management, information management, veterinary care, hardcopy imaging and RIS/PACS/reporting among others. The company provides services such as imaging services, IT-services and cloud & managed services. Agfa HealthCare operates through sales offices and representatives in around 100 markets all over the world. It operates as a subsidiary of Agfa-Gevaert NV. Agfa HealthCare is headquartered in Mortsel, Belgium.

GlobalData's new report, "Germany Cardiac Assist Devices Market Outlook to 2020", provides key market data on the Germany Cardiac Assist Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.

GlobalData's new report, "Australia Cardiovascular Surgery Market Outlook to 2020", provides key market data on the Australia Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables.

It is difficult for elderly people and people with disabilities to get quick help when they feel bad, especially when they are alone in home. Medical Alert Systems Reviews may help them to come out such problems.

Crossject is a medical device company. It manufactures and markets needleless drug self- injections. The company by using its needle-free injection system, ZENEO, develops a pipeline of high value SUPERGENERICS. Crossject's ZENEO is an advanced disposable, pre-filled, needle-free, automatic injection system. ZENO can deliver can deliver drugs intradermally, subcutaneously and intramuscularly. Crossject's pipeline portfolio includes methotrexate for rheumatoid arthritis; epinephrine for anaphylactic shock; and sumatriptan for acute migraine. It partners with bertin, hirtenberger, SCHOTT, and RECIPHARM. The company is an ISO: 13485 certified. Crossject is headquartered in Paris, France.

GlobalData's new report, "Russia Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Russia Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion diagnostic market for four major cancers in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this companion diagnostics market. This report analyses companion diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future of companion diagnostic tests. This report focuses on the major test kits that are supplied to pathology laboratories.